Genmab (Otc) (($GMAB)) announced an update on their ongoing clinical study. Genmab is currently conducting a Phase 3 clinical trial titled ‘A ...
Radiopharm Theranostics Limited (($AU:RAD)) announced an update on their ongoing clinical study. Study Overview: Radiopharm Theranostics Limited ...
MedPage Today on MSN
Checkpoint Blockade Finally Breaks Through in Ovarian Cancer
BERLIN -- After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall ...
A study presented at the annual European Society of Medical Oncology Congress 2025 and published in the journal Annals of ...
Merck Announces KEYTRUDA Plus WELIREG Met Primary Endpoint of DFS in Certain Patients With Clear Cell Renal Cell Carcinoma ...
Sacituzumab govitecan significantly improved survival outcomes for previously untreated, PD-L1-negative metastatic ...
Patients with PD-L1-positive metastatic triple-negative breast cancer reported improved emotional function and pain with sacituzumab govitecan plus pembrolizumab compared with chemotherapy plus ...
JSKN022 innovatively combines immuno-oncology (IO) mechanisms with ADC approaches, utilizing Alphamab Oncology's proprietary glycan-specific conjugation platform and linker-payload (Alphatecan) to ...
Patients with recurrent or metastatic squamous cell carcinoma (HNSCC), who had markers showing they would likely respond to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback